GL1X · GenesisL1 explorer

MolNFT v1 · #103862 · protein

Structure of a carboxamine compound (26) (2-{2-[(cyclopropylcarbonyl) AMINO]PYRIDIN-4-yl}-4-methoxypyrimidine-5-carboxamide) to GSK3B

4PTG · Glycogen synthase kinase-3 beta: “Structure of a carboxamine compound (26) (2-{2-[(cyclopropylcarbonyl)…”. X-ray diffraction, 1 ligand (2WG), 7 pockets (best druggability 0.74). MolNFT v1 #103862 on GenesisL1: 3D structure, binding…

PDB
4PTG
Type
protein
Length
665 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
2WG
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein33335% helix, 20% strandP49841
BGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein33236% helix, 21% strandP49841

Ligands and binding sites

  • 2WG · 2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18510.740.78702WG
2920.710.9527empty
36340.700.78542WG
4920.430.7927empty
5830.430.8023empty

Interfaces

1 interface between chains.

  • A–B · 830 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4PTG · Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.